Wealthfront’s Novo Nordisk NVO Stock Holding History

Wealthfront’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-3,700	Closed	-$101K	–	1370
2015 Q2	$101K	Buy	+3,700	New	+$104K	﹤0.01%	397

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Wealthfront's NVO Position: Q3 2015 in Review

Wealthfront sold out of Novo Nordisk (NVO) in Q3 2015, closing a stake of 3,700 shares — an estimated $101K sold.

Wealthfront first reported a position in NVO in Q2 2015 and held it in 1 quarter. The position peaked at $101K in Q2 2015. 525 funds tracked by Wall St. Rank hold NVO as of Q3 2015.

Wealthfront reported no remaining Novo Nordisk position as of Q3 2015 after selling out during the quarter.
Wealthfront sold 3,700 Novo Nordisk shares in Q3 2015, an estimated $101K.
Wealthfront first reported a position in Novo Nordisk in Q2 2015 and held it in 1 quarter.
Wealthfront's Novo Nordisk position peaked at $101K in Q2 2015.
525 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2015.

Based on Wealthfront's 13F filing for Q3 2015, filed 18 Nov 2015.